A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis. J of Skin [Internet]. 2019 Mar. 11 [cited 2025 Apr. 13];3(2):171. Available from: https://skin.dermsquared.com/skin/article/view/528